Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014)
Abeona Therapeutics' (ABEO) quarterly Other Non Operating Income came in at -$11.3 million in Q4 2014, down 37.8% year-on-year from -$18.2 million in Q4 2013, and down 1514.29% quarter-over-quarter from -$700000.0 in Q3 2014.
Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014) Analysis & Trends
Abeona Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$11.3 million for Q4 2014.
- On a quarterly basis, Other Non Operating Income fell 37.8% year-over-year to -$11.3 million in Q4 2014; TTM through Sep 2015 was -$11.3 million, a 43.53% increase from a year earlier, with the FY2025 full-year figure at $141000.0, changed N/A from the prior year.
- Other Non Operating Income retreated to -$11.3 million in Q4 2014 per ABEO's latest filing, from -$700000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $33.8 million in Q4 2012 and bottomed at -$13.9 million in Q3 2012.
- The 4-year median for Other Non Operating Income is $299500.0 (2012), against an average of -$239437.5.
- Biggest YoY gain for Other Non Operating Income was 1876.03% in 2012; the steepest drop was 1321.44% in 2012.
- Year by year, Other Non Operating Income stood at -$1.9 million in 2011, then soared by 1876.03% to $33.8 million in 2012, then tumbled by 124.27% to -$8.2 million in 2013, then slumped by 37.8% to -$11.3 million in 2014.
- Per Business Quant, the three latest ABEO Other Non Operating Income figures stand at -$11.3 million (Q4 2014), -$700000.0 (Q3 2014), and -$11.7 million (Q2 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -11.30 Mn |
| Sep 30, 2014 | -700,000.00 |
| Jun 30, 2014 | -11.69 Mn |
| Mar 31, 2014 | 583,000.00 |
| Dec 31, 2013 | -8.20 Mn |
| Sep 30, 2013 | 168,000.00 |
| Jun 30, 2013 | 3.27 Mn |
| Mar 31, 2013 | 4.78 Mn |
| Dec 31, 2012 | 33.78 Mn |
| Sep 30, 2012 | -13.90 Mn |
| Jun 30, 2012 | 431,000.00 |
| Mar 31, 2012 | -2.46 Mn |
| Dec 31, 2011 | -1.90 Mn |
| Sep 30, 2011 | 1.14 Mn |
| Jun 30, 2011 | 939,000.00 |
| Mar 31, 2011 | 1.24 Mn |